We serve Chemical Name:2,3,5,6-tetrafluoro-4-iodophenol CAS:1998-58-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2,3,5,6-tetrafluoro-4-iodophenol
CAS.NO:1998-58-9
Synonyms:4-iodotetrafluorophenol;2,3,5,6-Tetrafluor-4-iod-phenol;4-Iodo-2,3,5,6-tetrafluorophenol;Tetrafluor-2,3,5,6-iod-4-phenol;2,3,4,5-TETRAFLUOROBENZENEBORONIC ACID;Phenol,2,3,5,6-tetrafluoro-4-iodo;p-Iodotetrafluorophenol;4-Iod-2,3,5,6-tetrafluorphenol
Molecular Formula:C6HF4IO
Molecular Weight:291.97000
HS Code:2908199090
Physical and Chemical Properties:
Melting point:48-50ºC
Boiling point:220.1ºC at 760 mmHg
Density:2.303g/cm3
Index of Refraction:1.56
PSA:20.23000
Exact Mass:291.90100
LogP:2.55320
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-iodotetrafluorophenol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Iod-2,3,5,6-tetrafluorphenol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Tetrafluor-2,3,5,6-iod-4-phenol Use and application,Tetrafluor-2,3,5,6-iod-4-phenol technical grade,usp/ep/jp grade.
Related News: API and raw material are often confused due to the similar usage of the two terms. 2,3,5,6-tetrafluoro-4-iodophenol manufacturer Under the plan, nonessential hospital staff members who belong to the union would not go to work on Monday. 2,3,5,6-tetrafluoro-4-iodophenol supplier This decision has shaken the foundations of the scientific process and methods, said Dr. Jason Karlawish, co-director of the Penn Memory Center in Philadelphia. Karlawish ran one of the trial sites for the Biogen drug. 2,3,5,6-tetrafluoro-4-iodophenol vendor Under the plan, nonessential hospital staff members who belong to the union would not go to work on Monday. 2,3,5,6-tetrafluoro-4-iodophenol factory This decision has shaken the foundations of the scientific process and methods, said Dr. Jason Karlawish, co-director of the Penn Memory Center in Philadelphia. Karlawish ran one of the trial sites for the Biogen drug.
